Showing results (121-130 of 8,657) with videos related to
Sort By:
Pageof 866
Therapeutic Advances in Chronic Disease|January 16, 2016
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseasesDaniele D'Ambrosio, Mark S Freedman, Joerg PrinzThe Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 21, 2015
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to ManagementMoeber Mahzari, Amel Arnaout, Mark S FreedmanMultiple Sclerosis Journal - Experimental, Translational and Clinical|May 26, 2018
Clinical efficacy of teriflunomide over a fixed 2-year duration in the TOWER studyMark S Freedman, Julia Morawski, Karthinathan ThangaveluJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1976
Radionuclide determination of cardiac chamber flow/volume characteristicsG S Freedman, A Dwyer, J WolbergStatistics in Medicine|October 14, 2009
A modified approach to estimating sample size for simple logistic regression with one continuous covariateI Novikov, N Fund, L S FreedmanBiometrics|September 1, 1984
Stopping rules for clinical trials incorporating clinical opinionL S Freedman, D Lowe, P MacaskillJournal of Neurology|April 19, 2017
Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up studyArianna Sartori, Mohammad Abdoli, Mark S FreedmanMMWR. Morbidity and Mortality Weekly Report|February 11, 2021
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2021Mark S Freedman, Kevin Ault, Henry BernsteinSurvey of Ophthalmology|March 29, 2001
Management of glaucoma in pregnancy and lactationS M Johnson, M Martinez, S FreedmanNeurochemical Research|October 1, 1978
Effect of gamma-glutamyl cycle inhibitors on brain amino acid transport and utilizationS Samuels, I Fish, L S FreedmanPageof 866